RxDoctor Payments Data

Benjamin Collins, MD

Otolaryngology · Oklahoma City, OKNPI 1720422207

Payments from drug & device makers

What this record shows

Intersect ENT, Inc. accounts for 63.8% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2021 at $3,442 and has fallen 61.9% since, to $1,310 in 2025. Among otolaryngology clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,136in general payments, 2019–2025

Across 120 payments — averaging $84.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$6K
  • Sanofi$596
  • Stryker$589
  • Regeneron Healthcare Solutions, Inc.$391
  • Integra Lifesciences Corporation$344
  • Aerin Medical Inc.$325
  • plus $1K from 11 others

What the payments were for

  • Travel & lodging$4,36543%
  • Food & beverage$5,77157%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,136 in reported general payments places this provider in the 95th percentile of 109 otolaryngology providers in Oklahoma.

See all otolaryngology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$164,454
Medicare patients
345
Services billed
1,447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide126$3,119
Azelastine Hcl30$976
Ofloxacin35$637
Dexamethasone Sodium Phosphate14$590
Omeprazole53$509
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$393
Doxycycline Hyclate22$330
Fluticasone Propionate17$306
Mupirocin27$270
Montelukast Sodium39$241
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$150
Ondansetron OdtOndansetron15$74
Prednisone17$68
Pantoprazole Sodium12$56
Methimazole11$42

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →